NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)--Advaxis, Inc., (OTCBB: ADXS), the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, will host a science update investor conference call on Thursday, December 16, 2010 at 2:00 p.m. EST.
NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)--Advaxis, Inc., (OTCBB: ADXS), the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, will host a science update investor conference call on Thursday, December 16, 2010 at 2:00 p.m. EST.